Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion

Authors:

Abstract
No abstract available
Funding Information
  • Amgen
  • Kyowa Kirin Pharmaceutical Development
  • Astellas Pharma US
  • Chulalongkorn University
  • AstraZeneca
  • Novo Nordisk
  • GlaxoSmithKline
  • Vifor Pharma
  • Boehringer Ingelheim
  • Fresenius Medical Care North America
  • FibroGen

This publication has 28 references indexed in Scilit: